Morgan Stanley assumed coverage of Ultragenyx (RARE) with an Overweight rating and $64 price target The firm sees continued strong Crysvita ...
Monday, March 3, 2025, Eric Crombez, M.D., Chief Medical Officer, will participate in a fireside chat and host 1x1 meetings. Wednesday, March 12, 2025, Eric Crombez will participate in a fireside ...
Wednesday, March 12, 2025, Eric Crombez will participate in a fireside chat and host 1x1 meetings. The live and archived webcast of the fireside chat will be accessible from the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results